Era of partial replacement of doctors gaining impetus
Bio Spectrum|February 2020
Technology is assisting healthcare providers to make phenomenal gains by improving outcome in treatments by accurate diagnosis and treatment of diseases. Experts say that technological advancement in healthcare like adoption of digital pathology is expected to be the topmost choice in the healthcare industry, as it has proven to reduce the workload of physicians and clinicians. Additionally, it has also resulted in squeezing down the patient’s expenses due to more systemic approach in health systems enabled by technological developments.
Jyoti Pandey
Era of partial replacement of doctors gaining impetus

In 2019, the Indian government announced the shortage of doctors i.e. one doctor for 1,457 people, which is lower than the World Health Organisation (WHO) norms of 1:1000. In order to reach the recommended WHO doctor-patient ratio, India will need 2.3 million doctors by 2030. Nevertheless, the latest significant progress of the private health sector in India has come at a time when public spending on healthcare at 0.9 percent of gross domestic product (GDP).

Privatization leads to a sharp rise in the health expenditure in arrears to the increased cost of medical tests and medical consultations. Inefficient healthcare infrastructure in India is another contributing factor that restraints accessible healthcare delivery. Synopsizing in a sentence lack of trained medical professionals, low income, and inadequate medical facilities and infrastructure are the major challenges faced for accessible healthcare delivery in India.

Dr. Chirat Bhoraj, CEO Tricog Health, Bengaluru says, “The healthcare system suffers from a lack of affordable, accessible (quality) care for all, medical expertise will remain a scare recourse in the near-term, magnifying the impact of doctor and making them superefficient is an attractive solution, aggregating data enabled by the judicious use of technology like Artificial Intelligence (AI) will help to achieve this”.

The concern over these challenges is now putting more emphasis on innovative strategies and is expected to be rescued by the growing adoption of technology. According to Future Health Index, India accounted for 76 percent in terms of the adoption of health technologies by healthcare professionals and patients in the year 2019.

Bu hikaye Bio Spectrum dergisinin February 2020 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

Bu hikaye Bio Spectrum dergisinin February 2020 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

BIO SPECTRUM DERGISINDEN DAHA FAZLA HIKAYETümünü görüntüle
Early Diabetic Retinopathy Detection Remains a Challenge
Bio Spectrum

Early Diabetic Retinopathy Detection Remains a Challenge

The Vitreo Retinal Society of India (VRSI) and the Research Society for the Study of Diabetes in India (RSSDI) have formulated a first-of-its kind diabetic retinopathy (DR) screening guideline to help physicians and diabetologists in India educate their patients about DR.

time-read
2 dak  |
BioSpectrum India Nov 2024
Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time
Bio Spectrum

Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time

US-based Promega Corporation, a life-sciences research partner dedicated to providing intuitive tools that empower scientists to innovate, has unveiled the new GloMax Galaxy Bioluminescence Imager.

time-read
1 min  |
BioSpectrum India Nov 2024
Qiagen launches QIAcuityDx digital PCR system for clinical testing in oncology
Bio Spectrum

Qiagen launches QIAcuityDx digital PCR system for clinical testing in oncology

Qiagen N.V. has announced the launch of the QIAcuityDx Digital PCR System, a pivotal addition to its digital PCR portfolio now expanding into clinical diagnostics.

time-read
1 min  |
BioSpectrum India Nov 2024
Thermo Fisher introduces iCAP MX Series ICP-MS to simplify trace elemental analysis
Bio Spectrum

Thermo Fisher introduces iCAP MX Series ICP-MS to simplify trace elemental analysis

Thermo Fisher Scientific Inc. has launched the Thermo Scientific iCAP MX Series ICP-MS to simplify trace element analysis with inductively coupled plasma mass spectrometry (ICP-MS).

time-read
1 min  |
BioSpectrum India Nov 2024
Singleron, Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers
Bio Spectrum

Singleron, Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers

Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor of advanced life science products in India.

time-read
1 min  |
BioSpectrum India Nov 2024
IIT Madras identifies enhanced drug delivery method for eye treatments
Bio Spectrum

IIT Madras identifies enhanced drug delivery method for eye treatments

Researchers at the Indian Institute of Technology Madras (IIT-M) have demonstrated how drugs injected in the human eye can be better delivered to the target region through ‘convection caused by mild laser heating’.

time-read
1 min  |
BioSpectrum India Nov 2024
IIT Madras develops indigenous POCUS scanner for sports injury diagnosis
Bio Spectrum

IIT Madras develops indigenous POCUS scanner for sports injury diagnosis

A team of researchers at the Indian Institute of Technology Madras (IIT-M) has developed an indigenous portable Point-of-Care-Ultrasound (POCUS) Scanner for sports injury diagnosis and management.

time-read
1 min  |
BioSpectrum India Nov 2024
Practo strengthens Board with appointment of TVG Krishnamurthy and Dr Alexander Kuruvilla
Bio Spectrum

Practo strengthens Board with appointment of TVG Krishnamurthy and Dr Alexander Kuruvilla

Practo has appointed two new directors to its board: TVG Krishnamurthy and Dr Alexander Kuruvilla.

time-read
1 min  |
BioSpectrum India Nov 2024
Dr R N Gupta steps in as National President of Indian Pharmaceutical Association
Bio Spectrum

Dr R N Gupta steps in as National President of Indian Pharmaceutical Association

Dr R N Gupta has been elected as the National President of the Indian Pharmaceutical Association (IPA), the oldest and largest association of pharmaceutical professionals in the country, for the term 2024 - 2026 (October 1, 2024 - September 30, 2026).

time-read
1 min  |
BioSpectrum India Nov 2024
QR678 brings medtech leader Sridhar Ranganathan to advisory board
Bio Spectrum

QR678 brings medtech leader Sridhar Ranganathan to advisory board

QR678, a pioneering company dedicated to revolutionising hair and skin science through groundbreaking research and innovative solutions, has announced the appointment of Sridhar Ranganathan to its Board of Advisors.

time-read
1 min  |
BioSpectrum India Nov 2024